Latin-American Registry of Cardiovascular Disease and COVID-19: Rationale and Design of the CARDIO COVID 19-20 Registry
References
- Yan-Rong G, Qing-Dong C, Zhong-Si H, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res. 2020 Mar 13; 7(1): 11. DOI: 10.1186/s40779-020-00240-0
- Chen J. Pathogenicity and transmissibility of 2019-nCOV-A quick overview and comparison with other emerging viruses. Microbes Infect. 2020 Mar; 22(2): 69–71. DOI: 10.1016/j.micinf.2020.01.004
- WHO [internet]. Coronavirus disease (COVID-2019) situation reports; 2020. [Cited 2020 Mar 27]. Available in:
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situationreports . Accessed 27 Mar 2020. - Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. DOI: 10.1016/S1473-3099(20)30120-1
- Coronavirus COVID-19 Global cases. Baltimore, USA: Center for Systems Science and Engineering (CSSE) at Johns Hopkins University [Internet]; c22 Jan 2020. [Cited 2020 Mar 27]. Available in:
https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6 . - Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497–506. DOI: 10.1016/S0140-6736(20)30183-5
- Rodríguez-Morales AJ, Sánchez-Duque JA, Hernández-Botero S, et al. Preparación y control de la enfermedad por coronavirus 2019 (COVID-19) en América Latina. Acta Med Perú. 2020; 37(1): 3–7. DOI: 10.35663/amp.2020.371.909
- Xiong T-Y, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: Acute and long-term implications. Eur Heart J. 2020;
ehaa231 . DOI: 10.1093/eurheartj/ehaa231 - Zhou F, Yu T, Du R, Fan G. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020; 395: 1054–1062. DOI: 10.1016/S0140-6736(20)30566-3
- Hippisley-Cox J, Young D, Coupland C, et al. Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: Cohort study including 8.3 million people. Heart. 2020; 106: 1503–1511. DOI: 10.1136/heartjnl-2020-317393
- Lopes RD, Macedo AVS, de Barros E Silva PGM, et al. Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – The BRACE CORONA Trial. Am Heart J. 2020; 226: 49–59. DOI: 10.1016/j.ahj.2020.05.002
- Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020; 75(18): 2352–2571. DOI: 10.1016/j.jacc.2020.03.031
- Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA. 2020. DOI: 10.1001/jamacardio.2020.0950
- Rodriguez-Morales AJ, Gallego V, Escalera-Artezana JP, et al. COVID-19 in Latin America: The implications of the first confirmed case in Brazil. Travel Med Infect Dis. 2020; 35: 101613. DOI: 10.1016/j.tmaid.2020.101613
- Horwitz L, Nagovitch P, Sonneland HK, Zissis C. The coronavirus in Latin America. Americas Society Council of the Americas – AS COA.
https://www.as-coa.org/articles/coronavirus-latin-america#mexico .
DOI: https://doi.org/10.5334/gh.925 | Journal eISSN: 2211-8179
Language: English
Submitted on: Sep 21, 2020
Accepted on: Jan 13, 2021
Published on: Feb 12, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2021 Juan Esteban Gómez-Mesa, Stephania Galindo-Coral, Maria Claudia Montes, Walter Alarco, Jose Luis Barisani, Antonio Magaña, Eduardo R. Perna, Alexander Romero, Mario Speranza, Iván Mendoza, Fernando Wyss, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.